DIA/FDA Oligonucleotide-Based Therapeutics Conference

Agenda

Day 1 Oct 28, 2024

11:00 AM — 12:30 PM

Session 2 Track 2: Pro-Arrhythmic Risk of Oligonucleotide Therapeutics: Is New Guidance Needed?

1:30 PM — 3:00 PM

Session 3 Track 2: Translatability of CNS Safety and Pharmacology

Day 2 Oct 29, 2024

10:00 AM — 11:30 AM

Session 6 Track 2: Off Target Safety Assessment

Day 3 Oct 30, 2024

8:00 AM — 9:15 AM

Session 9 Track 2: Extra/Non-Hepatic Delivery

9:25 AM — 10:40 AM

Session 10 Track 2: Non-Clinical Safety Assessment of Oligonucleotides

Have an account?